CN108042512A - A kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide and its preparation method and application - Google Patents

A kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide and its preparation method and application Download PDF

Info

Publication number
CN108042512A
CN108042512A CN201810045838.0A CN201810045838A CN108042512A CN 108042512 A CN108042512 A CN 108042512A CN 201810045838 A CN201810045838 A CN 201810045838A CN 108042512 A CN108042512 A CN 108042512A
Authority
CN
China
Prior art keywords
alginate
andrographolide
polyacrylamide
hud typed
load
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810045838.0A
Other languages
Chinese (zh)
Other versions
CN108042512B (en
Inventor
薛伟明
张梦晨
温惠云
黄赛朋
贾朝
许宁侠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest University
Original Assignee
Northwest University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest University filed Critical Northwest University
Priority to CN201810045838.0A priority Critical patent/CN108042512B/en
Publication of CN108042512A publication Critical patent/CN108042512A/en
Application granted granted Critical
Publication of CN108042512B publication Critical patent/CN108042512B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

The invention discloses a kind of hud typed alginate/polyacrylamide microspheres for loading andrographolide and its preparation method and application, belong to novel pharmaceutical formulation preparing technical field.The microballoon is made of following components:Sodium alginate, polyacrylamide, andrographolide.The preparation method of alginate/polyacrylamide microsphere of present invention load andrographolide is electrostatic drop generation, have many advantages, such as that microballoon preparation efficiency is high, preparation condition is mild, Microsphere Size is controllable, micro-ball load is efficient, stability is good, can be widely applied to field of medical applications.Microballoon prepared by the present invention can be used for treatment infantile pneumonia, upper respiratory tract infection, has the function of immunological regulation, antitumor etc., can be widely applied to the fields such as health products, drug and bio-medical material.

Description

It is a kind of load andrographolide hud typed alginate/polyacrylamide microsphere and Its preparation method and application
Technical field
The invention belongs to novel pharmaceutical formulation preparing technical fields, are related to a kind of polymer microballoon and preparation method thereof, specifically It is related to a kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide and its preparation method and application.
Background technology
Andrographolide (C20H30O5) it is the diterpene ginkgolide extracted in acanthaceous plant Herba Andrographitis, in being One of principle active component of medicine Herba Andrographitis, chemical structural formula is shown in Figure 1A.Andrographolide has antipyretic, anti-inflammatory, antiviral, guarantor The effects that liver cholagogic, is clinically mainly used for treating the diseases such as the infection of the upper respiratory tract, pneumonia.Andrographolide is square prismatic or piece Shape crystallizes, and odorless, taste is extremely bitter, is soluble in acetone, methanol, ethyl alcohol, almost insoluble in water, 230~231 DEG C of fusing point.With other Common infection of the upper respiratory tract medicine is compared, and the antibacterial of andrographolide acts synergistically with antiviral with more preferably controlling Therapeutic effect, but because its oral bitter pole causes Treatment Compliance poor, particularly in infection of the upper respiratory tract pediatric population occurred frequently Curative compliance it is very poor.In order to solve the problems, such as this, the ripe dosage form developed at present includes pill, suspension, tablet etc., But still bitter taste cannot be sheltered well, and existing dosage form particle is larger, and single dose medicament contg is higher, is unsuitable for children (especially It is infant) administration.
Sodium alginate (Sodium Alginate) is《Pharmacopoeia of People's Republic of China》(2015 editions) include medicinal auxiliary Material, it is the linear anionic natural polysaccharide extracted from brown alga, sweet by α-L- guluronic acids and its stereoisomer β-D- The unbranched linear block copolymers that dew two kinds of structural units of uronic acid are polymerized by (1-4) glycosidic bond, chemical constitution Formula is shown in Figure 1B.Research show sodium alginate can in a mild condition with Ca2+It reacts and forms biocompatibility and mechanical strength is excellent Good calcium alginate gel, the three-dimensional network pore structure of gel provide material base for the load of drug with release.Ca2+Cause The mechanism that sodium alginate colloidal sol changes to gel state is:1 Ca2+4 coordinate bonds used with 2 GG segment units, which are formed, has 2 The stable chelate of six-membered ring structure, i.e. " egg lattice " structure, as shown in Figure 1 C.Fundamental reaction equation is as follows:
2n Na+-Alginate+n Ca2+→n Ca2+-Alginate↓+2n Na+
The preparation method of calcium alginate microsphere mainly has emulsion process, interfacial polymerization, spray drying process and electrostatic field drop Method etc..Wherein, there are microspheres product grain size is uneven, monodispersity is poor, drug for emulsion process, interfacial polymerization, spray drying process The common problems such as envelop rate is low and homogeneity is poor cause preparation of traditional Chinese medicine release behavior difference big.In addition, organic solvent residual It is the major reason for influencing product quality.Calcium alginate microsphere is prepared using electrostatic field droplet process, have monodispersity it is excellent, The advantages that uniform particle sizes are controllable, drug encapsulation efficiency is high and dosage is controllable, preparation condition is mild efficiently, organic solvent-free addition, Suitable for the high-efficient carrier of the multiple compounds such as cell and protein, nucleic acid.The basic principle of electrostatic field droplet process is:In raw material Liquid end, coagulating bath end load the positive electrode and negative electrode of electric field respectively.Under electric field force effect, the material liquid of positive terminal is said in miniflow Mouth can overcome solution surface tension and high throughput is spouting in the form of fine drop, subsequently into coagulation bath and Ca2+Reaction Form calcium alginate gel beads.By adjusting preparation condition parameter, gel beads grain size can be regulated and controled between 50~1000 μm.
Since the three-dimensional network pore structure of calcium alginate gel is more loose, be carried on encapsulated component therein be easy to Surrounding medium is spread, and is unable to reach effective control releasing effect.Existing research generally use polycationic compounds (rely as poly- Propylhomoserin, chitosan) it is reacted with calcium alginate microsphere, a layer-selective half is formed in microsphere surface by polyelectrolyte complex reaction Permeable membrane reaches and is encapsulated component in limitation microballoon and outwardly Medium Diffusion or makes what it was outwardly discharged with controlled rate Purpose.Although this polyelectrolyte membrane can effectively shield the leakage that cell is encapsulated in microballoon and control protein, nucleic acid, more The rate of release of the macromolecular components such as sugar, but preferable controlled release ability is had no to small molecule component, thus, relied using traditional gathering Propylhomoserin/calcium alginate or chitosan/calcium alginate microsphere cannot reach the taste masking effect to being encapsulated andrographolide.
The content of the invention
In order to overcome the problems of the above-mentioned prior art, it is an object of the invention to provide a kind of load andrographolides Hud typed alginate/polyacrylamide microsphere and its preparation method and application, the hud typed alginate/polyacrylamide Microballoon can effectively shelter andrographolide bitter taste, and drug loading is efficiently controllable, suitable for children novel form.
The present invention is realized by the following technical programs:
A kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide disclosed by the invention, the core In shell mould alginate/polyacrylamide microsphere, core is the alginate ball for loading andrographolide, and shell is polyacrylamide Amine;
Hud typed alginate/the polyacrylamide microsphere, in terms of mass fraction, including:1~8 part of sodium alginate gathers 1~6 part of acrylamide, 3~9 parts of andrographolide.
Preferably, the weight average molecular weight of the sodium alginate is 200000~800000, and the range of viscosities of 1% aqueous solution For 0.02~1Pas, the average molecular weight of polyacrylamide is 500000~5000000.
Preferably, a diameter of 50~2000 microns of the hud typed alginate/polyacrylamide microsphere.
Preferably, polyacrylamide can be replaced with the better polystyrene of biocompatibility and poly N-vinyl pyrrolidone It changes.
Hud typed alginate/polyacrylamide microsphere the invention also discloses above-mentioned load andrographolide is being made Application in the drug of the standby treatment infection of the upper respiratory tract or pneumonia.
Microballoon can effectively shelter the strong bitterness of andrographolide, expand the application range of andrographolide, particularly There is application advantage apparent in childrens respiratory tract infection and pneumonia treatment, be the new way for developing children.
The invention also discloses a kind of preparations for the hud typed alginate/polyacrylamide microsphere for loading andrographolide Method is prepared using electrostatic field sessile drop method, comprised the following steps:
1) sodium alginate is pressed:Andrographolide:Water=(0.5~3) g:(0.01~0.5) g:The amount ratio of 100mL, by sea Mosanom is soluble in water to be made into sodium alginate soln, adds andrographolide, and preparation obtains material liquid;
2) CaCl is pressed2:Acrylamide monomer:Water=(1~5) g:(0.1~2) g:The amount ratio of 100mL, by CaCl2It is dissolved in CaCl is made into water2Solution adds acrylamide monomer, and coagulation bath is made;
3) impulse electric field anode is connected with loading the syringe metal needle of material liquid, by impulse electric field cathode and gel Wire coil connection in bath, is then sprayed material liquid into coagulation bath by syringe metal needle;In course of injection, Sodium alginate and Ca in drop2+Crosslinking, forms calcium alginate, and drop is solidified into gel micro-ball and is wrapped in andrographolide Wherein;During drop is formed by curing gel micro-ball, acrylamide monomer molecule in coagulation bath by physical absorption and Molecule diffusion way is supported on the surface of calcium alginate gel bead, and using filter, washing, area load acrylamide list is made Body and the calcium alginate gel bead for encapsulating andrographolide;
Wire coil refers to, during electrostatic drop generation prepares microballoon, contains coagulation bath solution and contains acryloyl The container of the calcium chloride solution of amine is plastic culture dish or glass culture dish, and a wire coil ability is placed in the culture dish Make the cathode of coagulation bath solution make pulse electric field, and electrostatic field is formed between syringe and coagulation bath solution, in electric field force Under the action of realize gel micro-ball preparation.
4) it is micro- to the calcium alginate gel of area load acrylamide monomer made from step 3) and encapsulating andrographolide Ball carries out polymerization crosslinking reaction, is washed out, microballoon, drying is collected by filtration, and the hud typed seaweed of load andrographolide is made Hydrochlorate/polyacrylamide microsphere.
Preferably, in step 3), when injection, uses micro syringe that material liquid is made to pass through metal needle with the rate of 10mL/h Head pumps out.
Preferably, in step 4), the polymerization crosslinking reaction is by area load acrylamide monomer and encapsulating Herba Andrographitis After the calcium alginate gel bead of lactone is mixed with the solution containing crosslinking agent, initiator, catalyst, reaction 1~for 24 hours, solidifying Glue microsphere surface forms fine and close polyacrylamide shell;
Wherein, the mass ratio of crosslinking agent, initiator and acrylamide monomer is (50~200):(1~6):(100~ 2000)。
Preferably, the crosslinking agent is N, and N- methylene-bisacrylamides, the initiator is potassium peroxydisulfate or persulfuric acid Ammonium.
Preferably, containing crosslinking agent, initiator solution in be additionally added catalyst tetramethylethylenediamine, catalyst adds in It measures as the μ L of 50 μ L~400.
Preferably, in step 4), adopt and be washed with distilled water 3~5 times, then with 0.45 μm of filtering with microporous membrane, collect micro- Ball, vacuum drying is for 24 hours.
The invention also discloses the systems of hud typed alginate/polyacrylamide microsphere of another load andrographolide Preparation Method is prepared using gravitational field sessile drop method, comprised the following steps:
1) sodium alginate is pressed:Andrographolide:Water=(0.5~3) g:(0.01~0.5) g:The amount ratio of 100mL, by sea Mosanom is soluble in water to be made into sodium alginate soln, adds andrographolide, and preparation obtains material liquid;
2) CaCl is pressed2:Acrylamide monomer:Water=(1~5) g:(0.1~2) g:The amount ratio of 100mL, by CaCl2It is dissolved in CaCl is made into water2Solution adds acrylamide monomer, and coagulation bath is made;
3) material liquid is oozed into drop by syringe needle, drop is instilled into coagulation bath under the effect of gravity, drop In sodium alginate and Ca2+Crosslinking, forms calcium alginate, and drop is solidified into gel micro-ball and andrographolide is wrapped in it In, during drop is formed by curing gel micro-ball, the acrylamide monomer molecule in coagulation bath by physical absorption and divides Sub- diffusion way is supported on the surface of calcium alginate gel bead, and using filter, washing, area load acrylamide monomer is made And the calcium alginate gel bead of encapsulating andrographolide;
4) it is micro- to the calcium alginate gel of area load acrylamide monomer made from step 3) and encapsulating andrographolide Ball carries out polymerization crosslinking reaction, is washed out, microballoon, drying is collected by filtration, and the hud typed seaweed of load andrographolide is made Hydrochlorate/polyacrylamide microsphere.
Compared with prior art, the present invention has technique effect beneficial below:
Hud typed alginate/polyacrylamide microsphere of load andrographolide disclosed by the invention, the microballoon have The poroid space structure of three dimensional network, core are to contain the gel micro-ball that andrographolide formed by alginate, and shell is polyacrylamide; The microballoon can largely load andrographolide, have envelop rate high, and Microsphere Size is controllable, shelters bitter taste, increases in Herba Andrographitis The advantages that ester clinical application range, is studied for pharmaceutical carrier and provides development space with application.
One of method disclosed by the invention utilizes electrostatic field droplet process, makes the sodium alginate raw material of load andrographolide Drop enters in the calcium chloride coagulation bath containing acrylamide monomer molecule, during sol-gel phase transition occurs for drop, makes Acrylamide monomer molecule is incorporated in calcium alginate gel bead surface;By monomer polymerization reactions, the acryloyl of microsphere surface Amine monomers polymerize to form fine and close shell, achieve the purpose that control andrographolide rate of release, masking andrographolide bitter taste.
Another kind method disclosed by the invention makes sodium alginate and andrographolide mixed liquor using gravitational field droplet process (material liquid) is oozed with given pace by front end of the syringe needle syringe needle, and drop is instilled under the effect of gravity containing acrylamide monomer CaCl2In solution (coagulating bath).Sodium alginate and Ca in drop2+It is crosslinked and forms calcium alginate not soluble in water, drop It is formed by curing gel micro-ball and encapsulates andrographolide wherein.During drop is formed by curing gel micro-ball, solidification Acrylamide monomer molecule in bath is supported on calcium alginate microsphere surface by physical absorption and molecule diffusion way.By list Body polymerisation, the acrylamide monomer of microsphere surface polymerize to form fine and close shell, reach control andrographolide rate of release, Shelter the purpose of andrographolide bitter taste.
Microballoon disclosed by the invention can effectively shelter the strong bitterness of andrographolide, expand the application of andrographolide Scope particularly has application advantage apparent, is the new way for developing children in childrens respiratory tract infection and pneumonia treatment.
Description of the drawings
Figure 1A is andrographolide chemical structural formula;Figure 1B is alginate chemical constitution, and G is guluronic acid list in figure Member, M are mannuronic acid unit;Fig. 1 C are " egg lattice " structure of alginate and calcium ion gel;
Fig. 2 is the process flow chart that electrostatic drop generation prepares hud typed alginate/polyacrylamide microsphere;
Fig. 3 is alginate/polyacrylamide microsphere optical microscopic image;Wherein, (A) grain size is 450 μm -470 μm; (B) grain size is 230 μm -240 μm;
Fig. 4 is scanning electron microscopy picture;Wherein, (A) is alginate/polyacrylamide microsphere surface;(B) it is seaweed Hydrochlorate/polyacrylamide microsphere section;(C) calcium alginate microsphere surface;(D) it is calcium alginate microsphere section;
Fig. 5 is the infrared spectrum of alginate/polyacrylamide microsphere, N,N methylene bis acrylamide and acrylamide Analysis chart;
Fig. 6 is that the release of andrographolide in calcium alginate microsphere and hud typed alginate/polyacrylamide microsphere is bent Line chart;
Fig. 7 is the uv absorption spectra of acrylamide monomer and alginate/polyacrylamide microsphere leaching liquor.
Specific embodiment
With reference to specific embodiment, the present invention is described in further detail, it is described be explanation of the invention and It is not to limit.
Embodiment 1
Calcium alginate microsphere is prepared using electrostatic field sessile drop method:
By impulse electric field anode and it is mounted with 1% sodium alginates of 10mL and 0.1g andrographolides mixed liquor (material liquid) Syringe metal needle connection, by electric field cathode and 3%CaCl2Wire coil connection in solution (coagulation bath), thus Electrostatic field is formed between material liquid and coagulation bath.Use micro-injection pump that material liquid is made to pass through metal needle with the rate of 10mL/h It pumps out, under the action of electric field force, material liquid is overcome solution surface tension and is injected into the controllable drops of size solidifying Gu bath.Sodium alginate and Ca in drop2+It is crosslinked and forms calcium alginate not soluble in water, drop is formed by curing microballoon and will wear Heart lotus lactone wraps up wherein.By filtering, washing, the calcium alginate gel bead of encapsulating andrographolide is obtained.
Embodiment 2
Referring to Fig. 2, alginate/polyacrylamide microsphere is prepared using electrostatic drop generation:
By impulse electric field anode and it is mounted with 1% sodium alginates of 10mL and 0.1g andrographolides mixed liquor (material liquid) The connection of syringe metal needle, by the 3%CaCl of the acrylamide monomer containing 1.4g in electric field cathode and 25mL2Solution (gel Bath) in wire coil connection, so as to forming electrostatic field between material liquid and coagulation bath.Material liquid is made using micro-injection pump It is pumped out with the rate of 10mL/h by metal needle, under the action of electric field force, material liquid overcomes solution surface tension and with ruler Very little controllable drops are injected into coagulating bath.Sodium alginate and Ca in drop2+It is crosslinked and forms seaweed not soluble in water Sour calcium, drop are formed by curing microballoon and wrap up andrographolide wherein.During drop is formed by curing gel micro-ball, Acrylamide monomer molecule in coagulation bath is supported on calcium alginate microsphere surface by physical absorption and molecule diffusion way.Through Filtering and washing obtain area load acrylamide monomer molecule and encapsulate the calcium alginate gel bead of andrographolide.
By area load acrylamide monomer molecule obtained above and encapsulate andrographolide calcium alginate microsphere with 25mL distilled water is added in 50mL conical flasks, is started blender, then will be contained crosslinking agent 93mg N, N- methylene-bisacrylamides With the solution of 400 μ L 10mg/mL initiator potassium persulfates (ammonium persulfate), and 200 μ L tetramethylethylenediamines are added in simultaneously and are urged Agent makes the acrylamide of calcium alginate microsphere area load and crosslinking agent that polymerization crosslinking, reaction occur into 50mL conical flasks For 24 hours, fine and close polyacrylamide shell is formed in microsphere surface.It is washed with distilled water 3-5 times, with 0.45 μm of miillpore filter mistake Microballoon is collected in filter, is freeze-dried after washing for 24 hours to get hud typed alginate/pam microemulsion of load andrographolide Ball.
Its appearance structure is observed under an optical microscope, as a result referring to Fig. 3, wherein the grain size of (A) is 450 μm -470 μm, (B) grain size is 230 μm -240 μm.As can be seen that microsphere features smooth surface, pattern rounding, grain size is relatively uniform, and envelop rate It is high.Scanning electron microscope (SEM) photograph referring to Fig. 4, wherein, (A) be alginate/polyacrylamide microsphere surface;(B) it is alginate/poly- third Acrylamide microballoon section;(C) it is calcium alginate microsphere surface;(D) calcium alginate microsphere section;Alginic acid can be gone out to the eye Salt/polyacrylamide microsphere surface texture is continuous, and hole is less, and calcium alginate microsphere rough surface, and surface is broken It splits, there is larger hole;Section can be seen that alginate/polyacrylamide microsphere compared with calcium alginate microsphere more structure More fine and close, in alginate/polyacrylamide microsphere outermost layer, there are apparent shells, it was demonstrated that the alginate of preparation/poly- third There are nucleocapsids for acrylamide microballoon.
Referring to Fig. 5, be alginate/polyacrylamide microsphere (on), N, N- methylene-bisacrylamides (in) and propylene Amide (under) infrared spectrogram.2814cm is can be seen that from the infrared spectrogram of acrylamide-1The moderate strength absworption peak at place =CH is belonged in acrylamide2The stretching vibration of group;1613cm-1Neighbouring strong absworption peak belongs to the flexible of C=C keys and shakes It is dynamic.It can be seen that from the infrared spectrogram of alginate/polyacrylamide microsphere as=CH2It is changed into-CH2- when, 2814cm-1Locate the position transfer of absworption peak to 2925cm-1Near, 1613cm-1Neighbouring strong absworption peak disappears substantially, this can show Polymerisation generation polyacrylamide microsphere has occurred in acrylamide, and polyacrylamide bag is born in calcium alginate gel.
Embodiment 3
Andrographolide in calcium alginate microsphere and alginate/polyacrylamide microsphere is measured with ultraviolet specrophotometer Release:
Alginate/the polyacrylamide microsphere prepared in embodiment 1 and embodiment 2 and calcium alginate microsphere immersion are contained In the beaker for having 30mL distilled water, fully shaking in 37 DEG C of shaking tables is placed on.After 5min, 3mL aqueous solutions are pipetted from beaker, and 3mL distilled water is supplemented into beaker.10min, 20min, 30min, 45min, 1h, 2h, 3h, 4h, 5h, 6h, 8h, 10h, 12h, The experimental procedure is repeated for 24 hours.The two kinds of microballoons absorbance of andrographolide in distilled water at wavelength 226nm is measured respectively Value according to absorbance of the andrographolide in distilled water and concentration relationship standard curve and calculates its corresponding concentration, draws Release profiles of the andrographolide in two kinds of microballoons.As a result referring to Fig. 6, it can be seen that calcium alginate microsphere is in interior release for 24 hours Speed and burst size are all higher than alginate/polyacrylamide microsphere.
The envelop rate of alginate/polyacrylamide microsphere is measured with ultraviolet specrophotometer and drugloading rate is tested:
Alginate/the polyacrylamide microsphere prepared in embodiment 2 is broken into capsule (being crushed using mechanical means), and is placed It in 100mL methanol solutions, is sufficiently stirred with magnetic stirring apparatus, is completely dissolved andrographolide.Use ultraviolet specrophotometer Absorbance is measured at wavelength 236nm, according to the absorbance of andrographolide in methyl alcohol and concentration relationship standard curve, Calculate corresponding concentration.
Envelop rate=(Determination of Andrographolide in microballoon)/(andrographolide feed intake total amount)=67.2%
By the freeze-drying of the alginate prepared in embodiment 2/polyacrylamide microsphere, and precise its quality.
Drugloading rate=(Determination of Andrographolide in microballoon)/(microballoon gross mass after dry)=25.7% (g/g)
Embodiment 4
Residues detection of the acrylamide in alginate/polyacrylamide microsphere:
On the basis of embodiment 2, be added without drug andrographolide, be prepared the alginate of unsupported drug/ Polyacrylamide microsphere, and place it in distilled water, it is stirred at low speeds with magnetic stirring apparatus for 24 hours so that seaweed The acrylamide monomer that polymerisation is had neither part nor lot in hydrochlorate/polyacrylamide microsphere is fully diffused in distilled water.
With ultraviolet specrophotometer in the absorption spectrum that wave-length coverage is 200-400nm measure microballoon leachates.By 56mg Acrylamide is dissolved in 1mL distilled water, measures the absorption light of solution in 200-400nm wave-length coverages with ultraviolet specrophotometer Spectrum.Fig. 7 results are as it can be seen that acrylamide monomer has a strong absorption at 236nm wavelength, and alginate/polyacrylamide microsphere Without absworption peak at 236nm wavelength.It can draw, by way of membrane filtration washing, can remove and remain in alginate/poly- third The Residual acrylamide monomer for having neither part nor lot in reaction in acrylamide microballoon, so as to further illustrate the alginate of preparation/poly- third Acrylamide microballoon is not present because acrylamide monomer residual causes the neurotoxicity to human body, can prove the microballoon being prepared There is good biocompatibility.
In conclusion a kind of hud typed sodium alginate/pam microemulsion for loading andrographolide disclosed by the invention Ball, the microballoon are made of following components:Sodium alginate, polyacrylamide, andrographolide.Andrographolide alginic acid of the present invention Salt/polyacrylamide microsphere, which can effectively wrap up andrographolide, can simultaneously shelter bitter taste, increase the application range of drug.The present invention The preparation method of andrographolide alginate/polyacrylamide microsphere is electrostatic field sessile drop method, have microballoon preparation efficiency it is high, The advantages that preparation condition is mild, Microsphere Size is controllable, drug loading efficiencies are high, microballoon stability is good, can be widely applied to give birth to Object field of medical applications.Microballoon prepared by the present invention can be used for treatment infantile pneumonia, upper respiratory tract infection, have immune The functions such as adjusting, antitumor, can be widely applied to the fields such as health products, drug and bio-medical material.

Claims (10)

1. a kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide, which is characterized in that described hud typed In alginate/polyacrylamide microsphere, core is the microballoon formed by alginate load andrographolide, and shell is polyacrylamide Amine;
Hud typed alginate/the polyacrylamide microsphere, in terms of mass fraction, including:1~8 part of sodium alginate, polypropylene 1~6 part of amide, 3~9 parts of andrographolide.
2. hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 1, feature Be, the weight average molecular weight of the sodium alginate is 200000~800000, and the range of viscosities of 1% aqueous solution for 0.02~ 1Pas, the molecular weight of polyacrylamide is 500000~5000000.
3. hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 1, feature It is, a diameter of 50~1000 microns of the hud typed alginate/polyacrylamide microsphere.
4. hud typed alginate/pam microemulsion of the load andrographolide in claims 1 to 3 described in any one Application of the ball in the drug of the treatment infection of the upper respiratory tract or pneumonia is prepared.
5. a kind of preparation method for the hud typed alginate/polyacrylamide microsphere for loading andrographolide, which is characterized in that It is prepared, comprised the following steps using electrostatic field sessile drop method:
1) sodium alginate is pressed:Andrographolide:Water=(0.5~3) g:(0.01~0.5) g:The amount ratio of 100mL, by alginic acid Sodium is soluble in water to be made into sodium alginate soln, adds andrographolide, and preparation obtains material liquid;
2) calcium chloride is pressed:Acrylamide monomer:Water=(1~5) g:(0.1~2) g:The amount ratio of 100mL, calcium chloride are dissolved in water In be made into calcium chloride solution, add acrylamide monomer, be made coagulation bath;
3) impulse electric field anode with loading the syringe metal needle of material liquid is connected, by impulse electric field cathode and is placed in gel Wire coil connection in bath, is then sprayed material liquid with drops into coagulation bath by syringe metal needle, In coagulation bath, sodium alginate and calcium ion crosslinking in drop form calcium alginate gel, drop are made to be solidified into gel micro-ball simultaneously By andrographolide package wherein;During drop is formed by curing gel micro-ball, the acrylamide monomer in coagulation bath Molecule is supported on the surface of calcium alginate gel bead by physical absorption and molecule diffusion way, using filter, washing, is made Area load acrylamide monomer and the calcium alginate gel bead for encapsulating andrographolide;
4) to area load acrylamide monomer made from step 3) and encapsulate andrographolide calcium alginate gel bead into Row polymerization crosslinking react, be washed out, microballoon, drying be collected by filtration, be made load andrographolide hud typed alginate/ Polyacrylamide microsphere.
6. the preparation of hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 5 Method, which is characterized in that in step 3), use micro-injection pump that material liquid is made to be pumped with the rate of 10mL/h by metal needle Go out.
7. the preparation of hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 5 Method, which is characterized in that in step 4), the polymerization crosslinking reaction is by area load acrylamide monomer and encapsulating Herba Andrographitis After the calcium alginate gel bead of lactone is mixed with the solution containing crosslinking agent, initiator, reaction 1~for 24 hours, in gel micro-ball table Face forms fine and close polyacrylamide shell;
Wherein, the mass ratio of crosslinking agent, initiator and acrylamide monomer is (50~200):(1~6):(100~2000).
8. the preparation of hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 7 Method, which is characterized in that the crosslinking agent is N, and N- methylene-bisacrylamides, the initiator is potassium peroxydisulfate or persulfuric acid Ammonium.
9. the preparation of hud typed alginate/polyacrylamide microsphere of load andrographolide according to claim 7 Method, which is characterized in that containing crosslinking agent, initiator solution in be additionally added catalyst, wherein, catalyst be tetramethyl second Diamines, catalyst charge are the μ L of 50 μ L~400.
10. a kind of preparation method for the hud typed alginate/polyacrylamide microsphere for loading andrographolide, feature exist In, using gravitational field sessile drop method prepare, comprise the following steps:
1) sodium alginate is pressed:Andrographolide:Water=(0.5~3) g:(0.01~0.5) g:The amount ratio of 100mL, by alginic acid Sodium is soluble in water to be configured to sodium alginate soln, adds andrographolide, and preparation obtains material liquid;
2) calcium chloride is pressed:Acrylamide monomer:Water=(1~5) g:(0.1~2) g:The amount ratio of 100mL, calcium chloride is dissolved in Calcium chloride solution is made into water, adds acrylamide monomer, preparation obtains coagulation bath;
3) material liquid is oozed into drop by syringe needle, drop is instilled in coagulation bath under the effect of gravity, the sea in drop Mosanom and Ca2+Crosslinking forms calcium alginate gel, and drop is solidified into gel micro-ball and wraps up andrographolide wherein, During drop is formed by curing gel micro-ball, the acrylamide monomer molecule in coagulation bath is expanded by physical absorption and molecule Scattered mode is supported on the surface of calcium alginate gel bead, and using filter, washing, area load acrylamide monomer and bag is made Seal the calcium alginate gel bead of andrographolide;
4) to area load acrylamide monomer made from step 3) and encapsulate andrographolide calcium alginate gel bead into Row polymerization crosslinking react, be washed out, microballoon, drying be collected by filtration, be made load andrographolide hud typed alginate/ Polyacrylamide microsphere.
CN201810045838.0A 2018-01-17 2018-01-17 Andrographolide-loaded core-shell alginate/polyacrylamide microsphere and preparation method and application thereof Active CN108042512B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810045838.0A CN108042512B (en) 2018-01-17 2018-01-17 Andrographolide-loaded core-shell alginate/polyacrylamide microsphere and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810045838.0A CN108042512B (en) 2018-01-17 2018-01-17 Andrographolide-loaded core-shell alginate/polyacrylamide microsphere and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN108042512A true CN108042512A (en) 2018-05-18
CN108042512B CN108042512B (en) 2020-07-14

Family

ID=62126868

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810045838.0A Active CN108042512B (en) 2018-01-17 2018-01-17 Andrographolide-loaded core-shell alginate/polyacrylamide microsphere and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN108042512B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113041232A (en) * 2021-03-23 2021-06-29 上海市伤骨科研究所 Oral colon-targeted hydrogel for targeted intestinal blasting and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258481A (en) * 2011-08-19 2011-11-30 薛巍 Method for preparing self-assembled medicine-carried microspheres by combining high-voltage electrostatic liquid droplet method and layer-by-layer self-assembly method
CN105213317A (en) * 2014-07-01 2016-01-06 中国科学院大连化学物理研究所 A kind of hydrogel microsphere being embedded with blood coagulation relevant enzyme

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258481A (en) * 2011-08-19 2011-11-30 薛巍 Method for preparing self-assembled medicine-carried microspheres by combining high-voltage electrostatic liquid droplet method and layer-by-layer self-assembly method
CN105213317A (en) * 2014-07-01 2016-01-06 中国科学院大连化学物理研究所 A kind of hydrogel microsphere being embedded with blood coagulation relevant enzyme

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARSHIA SHARIFF等: "ENTRAPMENT OF ANDROGRAPHOLIDE IN CROSS-LINKED ALGINATE PELLETS: II. PHYSICOCHEMICAL CHARACTERIZATION TO STUDY THE PELLETIZATION OF ANDROGRAPHOLIDE", 《PAK.J.PHARM.SCI》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113041232A (en) * 2021-03-23 2021-06-29 上海市伤骨科研究所 Oral colon-targeted hydrogel for targeted intestinal blasting and preparation method and application thereof

Also Published As

Publication number Publication date
CN108042512B (en) 2020-07-14

Similar Documents

Publication Publication Date Title
CN1319637C (en) Chitose microsphere and microcapsule with uniform size and its preparation method
CN103040727A (en) Preparation method of drug and protein sustained-release alginate hybrid gel
WO2019139380A1 (en) Vitamin c-containing polycaprolactone microsphere filler and preparation method therefor
CN104840430B (en) A kind of chlorogenic acid chitosan microball and its preparation process and application
CN102977293B (en) Polymersome with dual response to ultrasound and pH and method for preparing same
CN101816627B (en) Synergistic treatment type multi-material sustained-release eye drop and preparation method
CN101703480A (en) Gelatin-chitosan/montmorillonite drug carried microspheres and preparation method thereof
CN103784396B (en) Ibuprofen oral micropill xerogel and preparation method thereof
CN102961362B (en) Beta-poly malic acid/chitosan nano drug sustained-release microcapsule and preparation method thereof
CN114983930B (en) ROS (reactive oxygen species) response type brain targeting nanogel bilayer drug release system based on high molecular polymer and preparation method and application thereof
CN107308112A (en) A kind of preparation method of modified xantham gum nano-micelle
CN103191441B (en) Method for preparing stimuli-response type esterified nano cellulose prodrug sustained-release material
CN108042512A (en) A kind of hud typed alginate/polyacrylamide microsphere for loading andrographolide and its preparation method and application
CN102784112B (en) Preparation method for porous slow-release microsphere of chitosan graft copolymer
CN104127386B (en) Rubimaillin/chitosan nanoparticle, and preparation method and application thereof
CN110590975A (en) Medicinal polyvinyl alcohol and preparation method thereof
CN110251487B (en) Preparation method and application of alcohol soluble protein nanoparticles for improving drug-loading rate and oral bioavailability of docetaxel
CN105504328B (en) A kind of room temperature coats the method for improving chitosan film blood compatibility in next step
CN105838013B (en) One kind is based on methyl vinyl ether maleic acid copolymer and the sensitive composite Nano gels of chitosan pH and preparation method thereof
CN104906040A (en) Amphiphilic block copolymer drug carrying micelle of K<+> responding type target intracellular drug releasing and preparation method thereof
CN111450078A (en) Electrostatic spinning nanoparticle-entrapped pharmaceutical preparation and application thereof
CN101838374B (en) Method for preparing crosslinked polymer nanometer micelle with structure simulating outer cell membranes
CN101513392A (en) Process for preparing slow and controlled micro pills
CN103751149A (en) Gamma-polyglutamic acid/gelatin nanoparticles loaded with water-insoluble drug and preparation method thereof
CN103724524A (en) Method for preparing glucose divinyl azelate/isopropylacrylamide copolymer nano-particle

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant